After An Upbeat J.P. Morgan, Three Biopharmas Look To Kick Off IPOs For 2024

 
• By Andrew McConaghie

Gene editing company Metagenomi and two oncology biopharmas will test the IPO waters soon – with hopes this could pave the way for others.

Share price movement
• Source: Shutterstock

More from Business

More from Scrip